Affiliate disclosure: As an Amazon Associate, we earn from qualifying purchases. This post contains affiliate links, which means we may earn a commission if you buy through them, at no extra cost to you.

The AREDS2 formula is the single most-cited reason eye vitamins are recommended for age-related macular degeneration, but the specific formula used in that NIH-funded trial has exact amounts — and many commercial products marketed as “AREDS2-based” quietly deviate from them, sometimes in ways that matter.

What the AREDS2 Trial Actually Tested

The Age-Related Eye Disease Study 2, funded by the National Eye Institute (part of the NIH), tested a specific daily formula in people with intermediate or advanced age-related macular degeneration in one eye. The exact daily amounts used were:

The copper is included specifically to offset a known side effect of high-dose zinc (copper deficiency), not as an independent eye-health ingredient — a detail that matters when checking whether a product is actually formula-complete.

Where Commercial Products Commonly Fall Short

Checking labels against this exact list reveals a few recurring gaps in products marketed as AREDS2-based:

Missing or reduced zeaxanthin. Lutein and zeaxanthin are frequently marketed together, but some products load up on lutein (which is cheaper to source) while providing well under 2 mg of zeaxanthin, or omit it entirely. Both were present in the actual trial formula, so a product missing zeaxanthin isn’t delivering the tested combination.

Zinc without the copper pairing. High-dose zinc without accompanying copper is one of the more common formulation shortcuts, since copper is a pricier ingredient — but this recreates a real risk the original trial specifically designed around (zinc-induced copper deficiency with long-term high-dose use).

Vitamin E and C substitutions. Some products substitute lower doses of vitamin C or E, or use different chemical forms than what was studied, without necessarily being lower quality, but making it harder to say the product matches the specific trial’s tested formula.

Why the Lower-Zinc Version Exists

The original AREDS2 trial actually tested two zinc doses head-to-head (80 mg and 25 mg) specifically because high-dose zinc can cause gastrointestinal side effects and other complications with long-term use in some people. The trial found comparable effectiveness between the two doses, which is why many currently marketed AREDS2-based products use the lower 25 mg zinc dose — this isn’t necessarily a formula falling short, but a legitimate alternative the same research supports, worth knowing so you don’t assume the higher dose is required.

Who the AREDS2 Formula Is Actually For

It’s worth being direct about this: the AREDS2 formula was studied specifically for people with intermediate or advanced AMD in at least one eye, not as general eye-health insurance for people without diagnosed AMD. There isn’t strong evidence this specific formula prevents AMD from developing in the first place in people without existing disease, which is a distinction eye vitamin marketing doesn’t always make clear. A comprehensive eye exam that identifies your actual AMD risk category is the appropriate starting point before deciding whether this specific formula is relevant to you at all.

👉 Compare current prices for AREDS2-formula eye vitamins on Amazon

How to Actually Check a Product Against This List

1. Find the supplement facts panel, not the front-of-package “AREDS2 formula” claim alone.
2. Check each of the six nutrients above individually against the trial amounts.
3. Confirm copper is present if zinc is dosed at 25 mg or higher.
4. Note whether the product uses the higher (80 mg) or lower (25 mg) zinc version — both are trial-supported, but they aren’t interchangeable with a product providing neither amount.

Our broader guide on eye vitamins and supplements for aging eyes covers additional product comparisons and how these nutrients fit into overall eye health beyond AMD specifically.

Why the Copper Pairing Specifically Matters

The inclusion of copper in the AREDS2 formula isn’t incidental — high-dose zinc supplementation, taken without copper, is a documented cause of copper deficiency over time, which can itself cause anemia and neurological symptoms. This is exactly the kind of formulation detail that gets lost when a product markets its zinc content prominently while quietly omitting or underdosing the copper meant to offset it.

Beta-Carotene: Removed From the Updated Formula for a Specific Reason

The original AREDS1 formula included beta-carotene, but AREDS2 specifically removed it after research found an increased lung cancer risk in smokers taking beta-carotene supplements — a genuinely important safety update that makes checking whether a product still includes beta-carotene (using the outdated original formula rather than the current AREDS2 version) particularly relevant for anyone who smokes or has a smoking history.

How AREDS2 Fits Into Broader Eye Health

This specific formula addresses AMD progression risk specifically, and doesn’t replace the broader eye health strategies covered in our guide on eye health over 60, including regular comprehensive exams that catch AMD and other conditions at their earliest, most treatable stages regardless of supplement use.

Testing and Monitoring If You Have AMD Risk Factors

For anyone with a family history of AMD or early signs identified during a routine eye exam, an ophthalmologist can help determine not just whether AREDS2 supplementation is appropriate, but also establish a monitoring schedule to track any progression — supplementation and monitoring work together rather than supplementation alone being a complete strategy.

Cost Considerations

AREDS2-formula supplements, particularly from reputable brands using the higher 80mg zinc dose, tend to cost more than generic multivitamins, reflecting the higher-dose, higher-quality ingredients required to actually match the studied formula — a reasonable investment specifically for people with confirmed intermediate or advanced AMD, less clearly justified as a preventive measure for people without this diagnosis.

Reading Third-Party Testing Labels

Given the specific, precise dosing requirements covered throughout this guide, third-party testing certification (USP, NSF, or ConsumerLab) provides added confidence that a product actually contains its labeled amounts of each of the six AREDS2 nutrients, rather than relying on the manufacturer’s own quality claims alone.

The Bigger Lesson About Supplement Marketing

The AREDS2 story reflects a pattern seen repeatedly across supplement categories on this site: a legitimate, well-designed clinical trial exists, but commercial products marketed around that trial’s name don’t always faithfully reproduce its exact formula — checking the specific numbers, rather than trusting the trial name alone, remains the most reliable way to bridge that gap.

Setting Realistic Expectations for Supplementation

Even a perfectly-matched AREDS2 formula doesn’t reverse existing AMD damage — the trial evidence supports slowing progression risk in intermediate-to-advanced AMD, not restoring vision already lost, an important distinction for setting realistic expectations about what this specific intervention can and cannot achieve.

Family History and Genetic Risk

AMD has a meaningful genetic component, and people with a first-degree relative with the condition face elevated risk — worth mentioning specifically during eye exams, since this family history can influence how proactively an ophthalmologist recommends monitoring and, potentially, earlier discussion of AREDS2 supplementation even before a formal AMD diagnosis.

Closing Thought

A few minutes spent checking a supplement facts panel against the six specific AREDS2 nutrients is a small effort that meaningfully improves the odds of actually getting the trial-matching protection this research was designed to provide.

Revisiting Your Supplement Choice Periodically

As with other evidence-based supplement choices covered throughout this site, periodically checking whether new research has updated AREDS2 guidance, or whether newer formulations have emerged, keeps your approach current rather than static based on information from when you first started supplementing.

Protecting vision is worth the small extra diligence this comparison requires.

One More Consideration: Combination With Other Eye Supplements

Some people take AREDS2-formula products alongside other eye-focused supplements like lutein-only or omega-3 products; checking for overlapping ingredients avoids inadvertently exceeding safe intake levels of any single nutrient across multiple products taken simultaneously.

The Value of Getting This Right

Macular degeneration is a leading cause of vision loss in older adults, and slowing its progression through a properly-matched supplement regimen is one of the more concrete, evidence-backed actions available — worth the modest additional effort of checking labels carefully against the specific formula this guide has covered in detail.

The Bottom Line

“AREDS2-based” on a label is a marketing claim, not a guarantee — the only way to know if a product actually matches the studied formula is checking the six specific nutrient amounts against the supplement facts panel directly. For anyone with diagnosed intermediate or advanced AMD, discussing the exact formula (including which zinc dose) with an ophthalmologist ensures the product matches what the evidence actually supports for that specific condition.

Your eye health is worth this small extra bit of label-reading diligence, especially given how much is at stake with vision specifically.

A well-informed choice today supports the vision you’ll rely on for many years to come.

Take the extra few minutes at the pharmacy shelf — your future eyesight is worth it.